Sickle cell disease (SCD) is a genetic disease that is due to single nucleotide polymorphism of the β-haemoglobin gene in the first ...

Cardiol Therapeutics is a binary, catalyst-driven biotech, with its investment case hinging on CardiolRx’s Phase III MAVERIC ...

In conclusion, in addition to the clinical benefits shown in the POET trial, oral step-down treatment reduced in-hospital bed ...

U.S. Secretary of Agriculture Brooke L. Rollins recently announced the Ranchers First Initiative, a sweeping package of actions to continue rebuilding the Great American Beef Herd and put America’s ...

In the world of name, image and likeness (NIL), those high school football players taking the field on Friday nights might already be millionaires. Long before they even make it to college football, ...

UPDATE (4:32 p.m.): In a news release, the El Paso County Sheriff's Office said one of the teenage boy victims is 15 years old, not 14. More charges may be forthcoming for the 14-year-old suspect as ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE) fell 13% to $94 on August 26, 2026, but the sell-off sharply overreacted to the underlying data.

Controlled-substance compliance and Schedule I manufacturing specialist brings experience in federal registration, controlled-substance operations, cGMP systems, quota administration, and DEA ...

Despite notable advancements in the acute and long-term management, coronary artery disease and myocardial infarction (MI) ...

A 65-year-old man was admitted to this hospital because of fever, intermittent abdominal pain, and rash. The fever began 5 weeks earlier, and palpable purpura developed 1 week before admission. A ...

Image source: The Motley Fool. Wednesday, Sept. 9, 2026 at 8:30 a.m. ET ...

Andrew Kuykendall, MD, lead investigator for the VERIFY trial supporting the approval, said rusfertide is used to treat erythrocytosis in polycythemia vera.